levofloxacin has been researched along with Chlamydia pneumoniae Infections in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 2 (100.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Burgmann, H; Kumbein, F; Lukas, A; Mayer, B; Oberbauer, R | 1 |
| Caronzolo, D; Colleoni, F; Fraschini, F; Grosso, S; Lucini, V; Pannacci, M; Scaglione, F | 1 |
2 other study(ies) available for levofloxacin and Chlamydia pneumoniae Infections
| Article | Year |
|---|---|
The influence of comorbidity on the effect of levofloxacin treatment success of ambulatory respiratory tract infections.
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Anti-Infective Agents; Child; Child, Preschool; Chlamydophila Infections; Chlamydophila pneumoniae; Cluster Analysis; Cohort Studies; Community-Acquired Infections; Comorbidity; Female; Haemophilus Infections; Humans; Levofloxacin; Male; Middle Aged; Ofloxacin; Pneumonia, Bacterial; Prospective Studies; Respiratory Tract Infections; Treatment Outcome | 2003 |
Glucocorticoids increase in vitro and in vivo activities of antibiotics against Chlamydophila pneumoniae.
Topics: Animals; Anti-Bacterial Agents; Anti-Inflammatory Agents; Azithromycin; Cell Line; Chlamydophila Infections; Chlamydophila pneumoniae; Dexamethasone; Drug Synergism; Glucocorticoids; Humans; Ketolides; Levofloxacin; Mice; Mice, Inbred BALB C; Microbial Sensitivity Tests; Ofloxacin | 2004 |